In the article on pharmacogenomics of EGFR inhibitors in the December 15, 2004 issue of Cancer Research (1), the correct spelling of the fifth author's name is George Cusatis.

1.
Amador ML, Oppenheimer D, Perea S, Maitra A, Cusatis G, Iacobuzio-Donahue C, Baker SD, Ashfaq R, Takimoto C, Forastiere A, Hidalgo M. An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors.
Cancer Res
2004
;
64
:
9139
–43.